These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22896595)

  • 1. Adaptation and antituberculosis drug-induced liver injury.
    Devarbhavi H
    Am J Respir Crit Care Med; 2012 Aug; 186(4):387-8; author reply 388-9. PubMed ID: 22896595
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence.
    Saukkonen JJ; Powell K; Jereb JA
    Am J Respir Crit Care Med; 2012 Mar; 185(6):598-9. PubMed ID: 22422902
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
    Singanayagam A; Sridhar S; Dhariwal J; Abdel-Aziz D; Munro K; Connell DW; George PM; Molyneaux PL; Cooke GS; Burroughs AK; Lalvani A; Wickremasinghe M; Kon OM
    Am J Respir Crit Care Med; 2012 Mar; 185(6):653-9. PubMed ID: 22198973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antituberculous therapy and acute liver failure.
    Caplin M; Thompson N; Hamilton M; McIntyre N; Burroughs A
    Lancet; 1995 May; 345(8958):1171. PubMed ID: 7786346
    [No Abstract]   [Full Text] [Related]  

  • 5. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxic effects of therapies for tuberculosis.
    Senousy BE; Belal SI; Draganov PV
    Nat Rev Gastroenterol Hepatol; 2010 Oct; 7(10):543-56. PubMed ID: 20808293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis treatment in adults].
    Gatey C; Bouvet E
    Rev Prat; 2012 Apr; 62(4):495-501. PubMed ID: 22641888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paying attention to the prevention and treatment of hepatic injury induced by anti-tuberculosis drugs].
    Tan SY
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):326-329. PubMed ID: 31137107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. Are liver function tests required for patients taking isoniazid for latent TB?
    Brown MO; Howard E; DeAlleaume L
    J Fam Pract; 2004 Jan; 53(1):63-5, 68. PubMed ID: 14709272
    [No Abstract]   [Full Text] [Related]  

  • 10. Antituberculous therapy and acute liver function.
    FitzGerald JM
    Lancet; 1995 May; 345(8958):1172. PubMed ID: 7723558
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
    Walker NF; Kliner M; Turner D; Bhagani S; Cropley I; Hopkins S; Lipman M
    Thorax; 2009 Oct; 64(10):918. PubMed ID: 19786720
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
    Jasmer RM; Daley CL
    Am J Respir Crit Care Med; 2003 Mar; 167(6):809-10. PubMed ID: 12623855
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(44):998-9. PubMed ID: 12455909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
    JAMA; 2001 Sep; 286(12):1445-6. PubMed ID: 11596606
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculosis of the Liver, Biliary Tract, and Pancreas.
    McMullan GS; Lewis JH
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28233514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The state of the liver in rabbits during combination chemotherapy of experimental disseminated tuberculosis].
    Mozhokina GN
    Probl Tuberk; 1990; (6):52-6. PubMed ID: 2217107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance and complications of antituberculosis chemotherapy].
    Duroux P
    Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Strengthen the study of anti-tuberculosis drug-induced liver injury in China].
    Tang SJ; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):323-325. PubMed ID: 31137106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.